The Body: The Complete HIV/AIDS Resource
Follow Us Follow Us on Facebook Follow Us on Twitter Download Our App 
Professionals >> Visit The Body PROThe Body en Espanol
Ask the Experts About

Choosing Your MedsChoosing Your Meds
Rollover images to visit our other forums!
Recent AnswersAsk a Question
  • Email Email
  • Glossary Glossary

Is this an ok combo?

May 22, 2008

Hi, my Dr just prescribed Viread 1x day,Ziagen 1-2x day, and, Kaletra 2-2x day, is this generally considered a good combo with least side effects? I previously tried Atripla and could not get over some of the side effects. Thank you for your time!

Response from Dr. Young

Hello and thanks for your post.

It sounds like this is still considered your first-line regimen. As such, I find it somewhat unconventional. There are a couple of ways to make your regimen consistent with current treatment guidelines- both would continue the Kaletra protease inhibitor, but alter the nukes.

First, you could continue the tenofovir, but in combination with FTC-- a drug called Truvada (ie, stop Ziagen).

Alternatively, you could stop the Viread, continue abacavir in combination with 3TC -- another combination pill called Epzicom or Kivexa.

Both options are currently considered preferred regimens in the US treatment guidelines.

I hope this helps.


Treatment time?
two pills in one day?

  • Email Email
  • Glossary Glossary

 Get Email Notifications When This Forum Updates or Subscribe With RSS



This forum is designed for educational purposes only, and experts are not rendering medical, mental health, legal or other professional advice or services. If you have or suspect you may have a medical, mental health, legal or other problem that requires advice, consult your own caregiver, attorney or other qualified professional.

Experts appearing on this page are independent and are solely responsible for editing and fact-checking their material. Neither nor any advertiser is the publisher or speaker of posted visitors' questions or the experts' material.

Review our complete terms of use and copyright notice.

Powered by ExpertViewpoint